Puxitatug - ≥99% , CAS No.2760250-47-1

CAS: 2760250-47-1 Cat. No.: P1433920
Disponível para encomenda
GRAU & PUREZA ≥99%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Tamanho
Alemanha (EU)
USA*
Preço
Qtd
1mg
P1433920-1mg
Sob encomenda · 8–12 semanas
261,10€
5mg
P1433920-5mg
Sob encomenda · 8–12 semanas
677,62€
Enter a quantity for the sizes you want to add.

Visão geral

Puxitatug is an immunoglobulin G1-κ, anti-[ Homo sapiens VTCN1 (Vset domain containing T cell activation inhibitor 1, B7 family member H4, B7H4, B7-H4 )] Homo sapiens monoclonal antibody.

Especificações

Especificações e pureza
≥99%
Condições de armazenamento de armazenamento
Store at -20°C
Enviado em
Ice chest + Ice pads
Este produto requer transporte de cadeia fria. Serviços terrestres e outros serviços econômicos não estão disponíveis.
Pureza
≥99%

Dados avançados

Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Application Protocols

No tested applications or validated protocols are provided for this specific item. The following are general, non-item-specific procedures for handling small molecules in screening workflows.

  • DMSO stock preparation (general):
    • Equilibrate vial to room temperature in a desiccator. Weigh desired amount (e.g., 1.0 mg) quickly. Add anhydrous DMSO to target 10 mM (volume depends on molecular weight; if unknown at weighing stage, dissolve to a known mass/volume and determine concentration later by UV or quantitative NMR once MW is available). Vortex and sonicate briefly if needed. Filter only if adsorption is negligible.
    • Aliquot into low-bind tubes or plates; store at -20°C.
  • Assay dosing (general):
    • Dilute stock into assay buffer to achieve final solvent ≤0.5–1% v/v. Include vehicle controls and, if relevant, positive control compounds.
  • Analytical check (general):
    • Verify concentration by LC–UV (calibration curve) or qNMR using an internal standard after MW is known. Confirm purity/identity by LC–MS.

These steps are intended as general laboratory practice. Consult your institutional SOPs and the item’s COA/SDS when available for parameterization.

Biological Roles

Item-specific biological roles, targets, or pathways for Puxitatug are not provided.

  • Known targets/pathways: Not specified for this item; refer to CoA/Spec Sheet or project data.
  • Mechanism of action: Not specified for this item; refer to CoA/Spec Sheet.

General considerations for small-molecule library members (not item-specific):

  • Such compounds are typically used to explore biochemical pathways in vitro or ex vivo. Any observed activity should be validated by orthogonal assays and counter-screens to exclude assay interference, aggregation, or redox cycling artifacts.
  • Establish basic ADME-relevant properties experimentally (solubility, stability in buffer/serum, microsomal stability) before interpreting biological readouts.
  • Use appropriate controls (vehicle controls, positive/negative reference compounds) and concentration-response curves to differentiate true target engagement from nonspecific effects.

Important: This product is designated for research use only. No clinical or diagnostic claims are made or implied. If biological use is intended, ensure compliance with institutional safety review and record any hazard flags from the SDS prior to live-cell or organism work.

Buffer Applications

This item is not a buffering agent, and no buffer-related specifications are provided. Therefore, dedicated buffer preparation guidance is not applicable to this product.

Practical notes for using small molecules in buffered systems (general, not item-specific):

  • Prepare compound stocks in DMSO or another suitable solvent, then dilute into assay buffer keeping final organic solvent ≤0.5–1% v/v to minimize biological interference.
  • To mitigate precipitation/adsorption, add compound to buffer containing 0.01–0.05% nonionic surfactant (e.g., Tween-20) when compatible with the assay.
  • If compound ionization is anticipated, choose buffer pH to favor solubility (e.g., acidic pH for basic compounds; basic pH for acidic compounds), provided the compound is stable under those conditions.
  • Filter solutions through 0.22 µm PTFE/RC filters only after confirming no adsorption losses.

For actual buffer recipes and pKa-dependent choices, consult standard buffer tables (phosphate, HEPES, Tris); these are outside the scope for this product without structural information.

Green Alternatives

This product is a small-molecule library member, not a commodity solvent or reagent with direct greener substitutes. However, greener choices can be applied to solvents used to dissolve and handle the compound (general guidance; not item-specific):

Sustainable solvent considerations for stock prep and assays:

  • Prefer water and aqueous buffers when chemical stability and ionization permit.
  • Use bio-derived ethers/esters such as 2-methyltetrahydrofuran (2-MeTHF) or ethyl acetate for extractions over chlorinated solvents when compatible with the unknown structure.
  • Favor ethanol over methanol where possible for reduced toxicity.

Small comparison (general):

  • DMSO vs. 2-MeTHF: DMSO excels for stock solutions (miscible with water; higher solvency). 2-MeTHF is a greener process solvent for workups but is not water-miscible and is unsuitable for aqueous assay dosing.
  • ACN vs. EtOH/H2O blends: ACN offers sharper LC peaks but is petroleum-derived; EtOH/H2O gradients can work for some analytical methods with greener profiles.

Operational tips:

  • Minimize organic solvent volumes via high-concentration master stocks and low final dosing percentages (≤0.5–1% v/v in assays).
  • Implement micro-scale chromatography or solid-phase extraction to cut solvent use during cleanup.
  • Capture and recycle high-purity ACN and MeOH from LC systems where feasible.
Pharmaceutical Uses
  • Pharmacopeial status: Not specified for this item; refer to CoA/Spec Sheet.
  • Excipient/application status: Not specified for this item; refer to CoA/Spec Sheet.

Context (general; not item-specific):

  • Library compounds such as this are supplied strictly for research use and are not manufactured under GMP suitable for human or veterinary administration.
  • Potential roles in a pharmaceutical R&D setting include reference standards for analytical method development, in vitro DMPK tools, or as discovery-stage screening actives/inactives in assay validation.
  • Any use in preclinical formulations (e.g., dosing vehicles for animal studies) requires full characterization of identity, purity, residual solvents, and stability, and must follow institutional and regulatory standards. Such uses are beyond the scope of this catalog entry unless explicitly stated on the COA.

No therapeutic or clinical claims are made for this product.

Physical Properties

Item-specific properties are not supplied in the Product Data. The following fields should be confirmed from the COA/SDS or by in-house characterization.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Purity/Grade: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (literature/unknown): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (literature/unknown): Not specified for this item; refer to CoA/Spec Sheet.
  • Density (literature/unknown): Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD (literature/unknown): Not specified for this item; refer to CoA/Spec Sheet.
  • pKa (literature/unknown): Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index (if liquid): Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility profile: Not specified for this item; refer to CoA/Spec Sheet.

General guidance for new, structure-unknown small molecules (general best practice, not item-specific):

  • Run a small solubility screen in dry DMSO, DMF, methanol, acetonitrile, and water (with/without 0.1% v/v base or acid if the compound is known to be stable to pH extremes). Start at 10 mM in DMSO as a default library stock concentration.
  • If crystalline, a sharp melting point suggests a single component; broad/depressed MP may indicate solvate or impurities. Confirm by DSC if needed.
  • Record UV–Vis spectrum (200–400 nm) to guide HPLC detection; avoid assigning a UV cutoff as a specification without COA support.
Quality and Grades
  • Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.

How to interpret typical grades for small-molecule library compounds (general guidance, not item-specific):

  • Library/Screening grade (typical, literature): Often supplied at ≥90–95% purity by LC or 1H NMR with accompanying LC–MS identity check. Water/peroxide/trace metal limits are seldom specified unless required for a particular application. Verify acceptance criteria on the COA before critical studies.
  • Stabilizers: If present (e.g., antioxidants, acid/base salts), these will be declared on the COA. Absence of a declaration does not guarantee absence—confirm analytically if stabilizer-free material is required.
  • Identity confirmation: For hits/controls, confirm by orthogonal methods (LC–HRMS, NMR) to rule out isomers/salts and assess counterion content if applicable.
  • Chromatography readiness: If using for HPLC/UPLC method development, choose solvent systems compatible with the compound’s UV profile; do not assume “HPLC grade” unless explicitly stated.

Recommendations for incoming QC (practical tips):

  • Record appearance and mass upon receipt; equilibrate from -20°C to ambient in a desiccator before opening.
  • Run a quick LC–MS purity/ID check using your platform’s standard gradient. If purity impacts assay performance, consider micro-purification prior to screening.
  • If salt form is unknown, determine net mass fraction of free base/acid by titration or quantitative NMR to prepare accurate molar stocks.
Reaction and Applications

Based on the Category Path, Puxitatug is positioned as a small-molecule library member. No specific reactivity or synthetic role is stated in the Product Data.

Applications (general for library compounds; not item-specific):

  • Discovery screening: Use as a test article in biochemical, biophysical, or phenotypic assays to probe pathways and generate SAR hypotheses.
  • Chemical biology: Potential starting point for probe development after orthogonal identity, purity, and stability confirmation.
  • Analytical reference: Use as an internal/external standard or system suitability test material once characterized.

Not typically used as a reagent:

  • In the absence of structure and functional group information, it is not advisable to position this material as a coupling partner, catalyst, or stoichiometric reagent.

Practical tips (general):

  • Prepare a verified concentration stock (e.g., 10 mM in DMSO) using mass/vial factor accounting for any salt/solvate once known.
  • Confirm stability in the intended assay matrix (e.g., incubation in buffer with 0.5% DMSO at 37°C, sampling by LC–MS over time).
  • For screening cascades, minimize freeze–thaw by aliquoting, and track plate map to control for edge effects and solvent gradients.

Mechanistic notes: Without structural data, discussion of reactivity, named reactions, or mechanistic behavior is not possible for this specific item.

Reaction Conditions

No reaction conditions are specified for this item, and the lack of structure precludes reliable literature inference.

General methodological guidance for handling unknown small molecules (not item-specific):

  • Stability scouting: Test small aliquots under representative conditions (e.g., pH 2, 7.4, 10; 25–60°C; light vs dark) and monitor by LC–MS to establish do’s and don’ts for any subsequent manipulations.
  • Solution handling: Prepare concentrated DMSO stocks (e.g., 10–50 mM) and dilute immediately before use to minimize hydrolysis/oxidation.
  • Avoid strong oxidants/reductants, strong acids/bases, and high temperatures until stability is proven.
  • If attempting chemical modification, run microscale reactions (≤5 mg) with broad screening of solvent/base/catalyst, guided by any revealed functional groups once structure is known.

Expected yields, catalysts, and temperature windows cannot be provided for this catalog item without structural information. Refer to the COA/SDS or request technical support if you obtain the structural details and require reaction planning assistance.

Safety and Handling

Safety data are not specified for this item in the Product Data. Always consult the SDS for authoritative guidance.

  • GHS classification (item-specific): Not specified for this item; refer to SDS.
  • Signal word / H-statements / pictograms: Not specified for this item; refer to SDS.

General laboratory precautions for an unknown small molecule (not item-specific):

  • Engineering controls: Handle in a certified chemical fume hood. Avoid aerosolization and dust generation.
  • PPE: Lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Upgrade to splash goggles/face shield if handling larger quantities or solutions under pressure.
  • Avoid inhalation, ingestion, and skin contact. Use closed transfer for DMSO stocks to reduce dermal exposure.
  • Incompatibilities: Unknown. As a precaution, segregate from strong oxidizers/reductants and strong acids/bases until compatibility is known.
  • First aid (overview): In case of contact, rinse with water for ≥15 min. If inhaled, move to fresh air. If ingested, do not induce vomiting; seek medical attention. Provide SDS to responders.
  • Spill/accident: Contain with inert absorbent (for solutions) or dampen solids to avoid dust. Dispose as hazardous chemical waste per institutional protocol.
  • Thermal/light sensitivity: Unknown. Protect from heat and light by default until stability data are available.

Storage per Product Data:

  • Store at -20°C in a tightly closed container. Shipments are provided in an ice chest with ice pads. Allow controlled equilibration to room temperature before opening to minimize condensation.
Solvent Selection

Item-specific solubility and polarity are not provided. The following decision framework is general best practice for small molecules in discovery (not item-specific):

  • Primary stock solvent:
    • DMSO is the default for library stocks (e.g., 10–50 mM). It dissolves a wide range of scaffolds and is compatible with many bioassays at ≤0.5–1% v/v final.
  • Secondary options if DMSO is insufficient or undesirable:
    • DMF or NMP (higher solvating power; check cytotoxicity in cell assays).
    • Methanol or acetonitrile for analytical prep and LC sample dissolution.
    • Aqueous buffers: Only if the compound bears ionizable groups and is stable; adjust pH cautiously.
  • Cosolvent strategies:
    • Use small volumes (5–20% v/v) of DMSO/MeOH in buffer with surfactants (e.g., 0.01–0.05% Tween-20) to minimize precipitation and adsorption (general guidance).
  • Avoid:
    • Strongly basic or acidic media unless stability is known. Minimize freeze–thaw of DMSO stocks to reduce crystallization and hydrolysis.

Comparison (general, not item-specific):

  • DMSO: broad solubility, good storage stability; biological tolerability limited to low %.
  • MeOH/ACN: volatile, LC-friendly; poorer solubility for highly lipophilic compounds.
  • DMF/NMP: strong solvents; potential toxicity and assay interference—use sparingly.

Tip: Run a mini solubility screen (DMSO, DMF, MeOH, ACN, water, pH 2/7/10) on 0.5–1 mg to map practical working solvents.

Storage and Reconstitution

Item-specific storage/shipping (from Product Data):

  • Storage: Store at -20°C.
  • Shipped in: Ice chest + ice pads to maintain a cold chain during transit.

General handling and reconstitution guidance for small-molecule solids/solutions (not item-specific):

  • Upon receipt, allow the sealed container to equilibrate to room temperature before opening to prevent moisture condensation. If possible, handle in a desiccator.
  • Keep container tightly closed. Protect from moisture and, absent contrary data, from light as a precaution.
  • For solution stocks (e.g., in DMSO):
    • Prepare concentrated stocks (e.g., 10–50 mM) and store as single-use aliquots at -20°C to minimize freeze–thaw. Record solvent, concentration, and preparation date on the label.
    • Avoid repeated thawing; thaw on ice or at room temperature, mix gently, and inspect for precipitation before use.
  • Stability/shelf-life: Not specified for this item; refer to CoA/Spec Sheet. Confirm stability periodically by LC–MS/LC–UV.

Research-use only: This product is intended strictly for laboratory research. For any extended storage or special stabilization requirements (desiccants, inert atmosphere), defer to the COA/SDS once provided.

Structure and Identity

Brief overview: Puxitatug (SKU P1433920) is listed in our small-molecule compound library. Structural identifiers have not been provided for this catalog entry.

  • Item-specific identifiers (from Product Data)

    • Product Name: Puxitatug
    • SKU: P1433920
    • CAS: 2760250-47-1
    • Category: Small molecules and compound library (小分子和化合物库)
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • InChI / InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features

    • Not available in the Product Data. Without a formula/structure, functional groups, ring systems, stereochemistry, and a 2D description cannot be stated. Please consult the COA/SDS or request the structure file (SDF/MOL) if available for your program.
  • Registry and informatics

    • If you maintain internal databases, index this entry under CAS 2760250-47-1 and your Aladdin reference SKU P1433920 pending receipt of definitive structural metadata.
  • Research-use designation

    • For research use only (per Product Data). No medical or clinical applications.
Synthetic Utility

Item-specific functional groups and reactivity are unknown from the provided data; therefore, detailed synthetic roles cannot be assigned.

General possibilities for small molecules in a chemistry workflow (not item-specific):

  • Analytical control: Serve as a comparator material or spike-in standard for validating LC–MS or NMR methods after identity confirmation.
  • Derivatization/probe development: If and only if the structure is available and contains modifiable handles (e.g., halides, amines, carboxylates), the scaffold might be derivatized to explore SAR or to append reporter tags. This is speculative until structural data are provided.
  • Stability mapping: Conduct forced degradation (acid/base, oxidative, photolytic, thermal) to define degradation pathways, which can inform synthetic protection strategies or salt selection.

Limitations:

  • Without SMILES/structure, no guidance can be given on named reactions, cross-couplings, or protecting-group tactics for this specific item.

Recommendation:

  • Obtain or request the structural file (SDF/MOL), verify by LC–HRMS and NMR, then plan any synthetic elaboration accordingly. Document salt/solvate state to ensure accurate stoichiometry in transformations.
Target Specificity

Item-specific biological target(s), binding profile, or selectivity data are not provided for Puxitatug.

  • Target(s): Not specified for this item; refer to CoA/Spec Sheet.
  • Species reactivity / selectivity: Not specified for this item; refer to CoA/Spec Sheet.
  • Assay-confirmed potency/affinity: Not specified for this item; refer to CoA/Spec Sheet.

If used in discovery biology (general guidance, not item-specific):

  • Establish target engagement with orthogonal methods (e.g., thermal shift/DSF, SPR, CETSA, enzymatic IC50 with counterscreens for assay interference).
  • Profile selectivity against related protein families if an initial activity is found.
  • Evaluate aggregation and redox-activity risks (e.g., DLS, detergent sensitivity, resazurin interference tests) to rule out pan-assay interference.

Perguntas frequentes

What is the purity of this product?
This product is supplied at ≥99% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 2760250-47-1.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.